Enzo Ventures
Enzo Ventures is a venture capital firm based in Barcelona, founded in 2023 by Edgar Vicente and Iván Fernández Lucas. The firm focuses on early-stage startups from Southern Europe and its diaspora. Comprised of a small, dedicated team, Enzo Ventures differentiates itself by investing in founders from this region, even those who relocate to global hubs like London and Paris. Enzo Ventures emphasizes a human-centric investment approach that deeply values personal connections.
The firm targets pre-seed investments in sectors such as AI, Fintech, and Logistics, with typical check sizes ranging from $250,000 to $600,000. They focus on Southern Europe but support companies building globally. Enzo Ventures has a total of €30 million in assets under management across two funds: Fund I (€10 million) and Fund II (€20 million). The firm has gained confidence from family offices across Europe and Mexico, with significant reinvestment from initial investors.
Enzo Ventures' portfolio includes notable companies like Orbio AI - an AI-driven HR systems provider, Murphy AI - an AI tool for debt collection, and Complaion - a compliance solutions provider. Other investments include Cori Clinical, a healthcare startup based in London, emphasizing their commitment to supporting Southern European founders regardless of their physical location.
EOS Investimentos
EOS Investimentos is an independent asset management company. We manage in the global interest, currency and equity markets, but mainly in Brazil. More than R $ 1.7 billion * under management.
EOS Private Equity
Eos is an alternative investment firm with approximately $1.5 billion of capital under management. Eos is an active investor in the credit, public equity and private equity markets and has a long/short credit strategy dedicated to socially responsible investing.
PRIVATE EQUITY
Our goal is to partner with superior management teams and commit our professionals' collective business experience, network of relationships, strategic judgment, and financial markets expertise in order to elevate these businesses to the next level.
CREDIT OPPORTUNITIES
Eos Credit Opportunities is a value-oriented, long-biased credit fund with a proven track record of investing within the liquid credit spectrum through multiple credit cycles.
EQUITY STRATEGIES
Eos Focused Equity employs a long-biased, value oriented equity strategy with a core focus on event-driven and special situations, turnarounds, post bankruptcies, and recapitalizations.
EPIC Private Equity
EPIC Private Equity is a private equity firm believed to be based in Europe. At present, specific details about their founding year, founders' backgrounds, or team size are not available. The firm showcases a focus on providing strategic investment solutions and working closely with their portfolio companies for value creation and growth.
Their investment strategy tends to target middle-market companies, across a varied set of industries. This includes, but is not limited to, sectors like healthcare, technology, and consumer services. While the specific check sizes are not disclosed, they likely invest in growth stages of firms. The firm's total assets under management or specific fund details are not provided on their website.
Notable portfolio companies or detailed investment specifics are not accessible at the moment. This limits the insights into their previous investments and the impact their engagements have had on these companies.
EPIC Ventures
EPIC Ventures is a venture capital firm based in Salt Lake City, Utah, specializing in early-stage investments in software and internet infrastructure companies. Founded in 1994 and originally backed by Zions Bank, the firm focuses on technology companies with high-growth potential across various industries. EPIC Ventures manages multiple investment funds and is actively involved in the Mountain and Western states, as well as seeking opportunities in the Northeast and Northwest regions of the United States.
The firm takes an active investment approach, aiming for board representation in its portfolio companies. EPIC Ventures offers strategic guidance and resources to help these companies scale, leveraging the operational and financial expertise of its partners and a broad network of industry contacts. The leadership team includes managing partners Jack Boren, Kent Madsen, and Nick Efstratis, with Nick Buroker serving as Chief Financial Officer. The firm partners with organizations such as ARUP Laboratories and University of Utah Ventures.
Epicure Capital Partners
Epicure specialises in all types of international commercial representation development, training and consultancy. Since its creation in 2003, it has been assisting and providing support to companies seeking to move to, or grow, in foreign markets around the world (including in European markets and Belgium). Epicure shares its knowledge of, and expertise in, specific and complex markets. Developing these markets yourself requires a significant human resources and financial investment. There is also the potential for error resulting from a lack of knowledge about local rules and cultures.
Epidarex Capital
Epidarex Capital is a venture capital firm based in Bethesda, Maryland, founded in 2010. The firm is led by a diverse team of early-stage investors focused on building breakthrough life science companies in emerging hubs. With a team of around 10 professionals, Epidarex leverages deep scientific and industry networks to create exceptional value for its portfolio companies.
Epidarex Capital invests primarily in life sciences, biotechnology, pharmaceuticals, medical devices, and health technology sectors. The firm targets early-stage investments, particularly in Series A rounds, with a focus on companies based in the United States and the United Kingdom. Epidarex manages several funds, including Epidarex Capital II with $47 million AUM and Epidarex Capital III with $105 million AUM.
Notable investments by Epidarex Capital include RapidPulse - stroke aspiration technology, Mironid - therapeutic devices, Leucid Bio - drug discovery, Epsilogen - drug discovery, and Theolytics - drug discovery. These investments highlight the firm's commitment to advancing innovative solutions in the life sciences sector.
Epiphany Ventures
Epiphany (Pronunciation: i- pif -uh-nee) is a moment of sudden and great revelation, or realization. They believe, that at the core of all successful businesses, is an 'epiphany'. Their mission is to partner entrepreneurs with such epiphanies, and help them turn their vision into reality.
<br />
Epiphany Ventures has raised $25 million to invest in early stage, path-breaking businesses. Their fund is sector-agnostic, and aims to invest in value-driven, innovative, and scalable business opportunities. They like to work with highly motivated, creative and focused groups of people who readily possess the intelligence, determination, and perseverance to create the "next big thing" in their sector. Epiphany Ventures, typically, invests at a stage where the company has successfully demonstrated a strong proof of concept, through customer acceptance. Epiphany regularly networks with industry and thought leaders, and therefore, backs financial capital with expertise gained from years of experience, and a plethora of knowledge. The ticket size of their investments ranges from $0.5 million to $3 million. Epiphany is open to co-investing in larger deals, by collaborating with other funds or HNIs from its network
Epiris LLP
Epiris LLP is a private equity firm based in the UK that transforms domestic and international businesses by partnering with exceptional management teams. Founded with the goal of building great businesses that deliver outstanding returns for investors, Epiris is driven by a highly experienced team. They manage over £2.75 billion of capital and have a track record of investing through business and economic cycles. Their team comprises 12 investment professionals who have worked together for many years.
Epiris specializes in transforming businesses across various sectors, focusing on opportunities that demonstrate potential for growth and expansion. They invest in companies within a wide range of industries such as Business Services (B2B), Healthcare Services, Industrial, and Consumer Products. While specific details of their investment sizes are not explicitly stated, their activity suggests they operate within the mid-to-large market space. They emphasize strategic partnerships and have a robust portfolio, serving as trusted partners to leading private equity investors.
Some notable companies in their portfolio include Audiotonix - professional audio mixing equipment, Stuart Turner - pump manufacturer, Gamma Communications - communication services provider, and Pure Cremation - direct cremation services. Their investments exhibit a diverse strategy aimed at unlocking potential and driving company growth across multiple sectors.
Episode 1 Ventures
Episode 1 Ventures is a venture capital firm based in the United Kingdom. The firm focuses on early-stage investments, specifically targeting Pre-Seed and Seed B2B software companies aiming to reach a successful Series A. Their team emphasizes quick decision-making and long-term engagement, fostering strong relationships with founders from the outset.
Episode 1 Ventures invests primarily in B2B software, with an eye on getting startups from their early beginnings through to a successful Series A round. They focus geographically on the UK and Europe, providing investment sizes typically in the range of $0-1 million, which aligns with typical early-stage (Pre-Seed to Seed) investment strategies. The firm is known for its hands-on approach and providing consistent support to its portfolio companies.
Among their notable investments are Adsum - business tax refunds; Sano Genetics - accelerating personalized medicine; CloudNC - AI manufacturing co-pilot; Raft - automating the freight journey; and Robin AI - AI-driven contracts review. They are recognized for their strategic guidance, particularly in areas such as go-to-market strategy and fundraising.